SMTL ID : 4y14.1 (1 other biounit)

Structure of protein tyrosine phosphatase 1B complexed with inhibitor (PTP1B:CPT157633)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

3 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 3 residues within 4Å: Chain A: L.42, P.43, K.44 Ligand excluded by PLIP CL.2: 5 residues within 4Å: Chain A: Y.25, R.29, R.259, G.264, Q.267 Ligand excluded by PLIP CL.3: 3 residues within 4Å: Chain A: R.117, V.118, H.180 Ligand excluded by PLIP

2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)

TRS.4: 2 residues within 4Å: Chain A: A.23, D.27 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.27 Water bridges: A:D.27 TRS.5: 3 residues within 4Å: Chain A: K.133, E.134, E.135 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:E.134, A:E.134, A:E.134, A:E.135 Water bridges: A:E.134, A:E.135

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.6: 6 residues within 4Å: Chain A: P.94, C.97, A.127, Q.128, M.138, F.140 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:P.94 Water bridges: A:G.98, A:G.98

1 x C0A: 3-bromo-4-[difluoro(phosphono)methyl]-N-methyl-Nalpha-(methylsulfonyl)-L-phenylalaninamide(Non-covalent)

C0A.7: 13 residues within 4Å: Chain A: Y.51, D.53, V.54, D.186, F.187, C.220, S.221, A.222, G.223, I.224, G.225, R.226, Q.267 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:Y.51, A:Y.51, A:V.54, A:F.187, A:A.222, A:I.224, A:I.224 Hydrogen bonds: A:D.53, A:S.221, A:A.222, A:G.223, A:I.224, A:G.225, A:R.226, A:R.226, A:R.226 Water bridges: A:F.187

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Krishnan, N. et al., PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J.Clin.Invest. (2015)

Release Date

2015-08-05

Peptides

Tyrosine-protein phosphatase non-receptor type 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 1

Related Entries With Identical Sequence